Sight Sciences Inc
NASDAQ:SGHT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.72
8.31
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SGHT stock under the Base Case scenario is 6.9 USD. Compared to the current market price of 4.66 USD, Sight Sciences Inc is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Sight Sciences Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SGHT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Sight Sciences Inc
Balance Sheet Decomposition
Sight Sciences Inc
Current Assets | 146.3m |
Cash & Short-Term Investments | 118.2m |
Receivables | 19.9m |
Other Current Assets | 8.2m |
Non-Current Assets | 3.4m |
PP&E | 2.7m |
Other Non-Current Assets | 640k |
Current Liabilities | 13.3m |
Accounts Payable | 1.9m |
Accrued Liabilities | 11.4m |
Non-Current Liabilities | 34.8m |
Long-Term Debt | 33.8m |
Other Non-Current Liabilities | 1m |
Earnings Waterfall
Sight Sciences Inc
Revenue
|
79.4m
USD
|
Cost of Revenue
|
-11.3m
USD
|
Gross Profit
|
68.1m
USD
|
Operating Expenses
|
-120m
USD
|
Operating Income
|
-51.9m
USD
|
Other Expenses
|
-432k
USD
|
Net Income
|
-52.3m
USD
|
Free Cash Flow Analysis
Sight Sciences Inc
USD | |
Free Cash Flow | USD |
In the second quarter, the company generated a total revenue of $21.4 million, demonstrating an 11% sequential growth but a 9% decrease compared to the previous year. The Surgical Glaucoma segment performed well with $20.2 million in revenue, an 11% increase sequentially, despite a 5% year-over-year decline. The company expects double-digit revenue growth in this segment in the second half of 2024. However, the Dry Eye segment faced a 46% revenue drop year-over-year due to a strategic shift. Guidance for full-year 2024 revenue has narrowed to $81-$83 million, with expectations of reduced third-quarter revenue due to seasonality and lower TearCare demand.
What is Earnings Call?
SGHT Profitability Score
Profitability Due Diligence
Sight Sciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Sight Sciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
SGHT Solvency Score
Solvency Due Diligence
Sight Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Sight Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SGHT Price Targets Summary
Sight Sciences Inc
According to Wall Street analysts, the average 1-year price target for SGHT is 7.53 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for SGHT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SGHT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sight Sciences, Inc. is a medical device company, which engages in the provision of glaucoma implants for treatment of irreversible blindness. The company is headquartered in Menlo Park, California and currently employs 212 full-time employees. The company went IPO on 2021-07-15. The firm is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The firm operates through two segments: Surgical Glaucoma and Dry Eye. Its Surgical Glaucoma segment consists of sales of the OMNI surgical system. Its Dry Eye segment includes sales of the TearCare system and related components and accessories. The Company’s Surgical Glaucoma segment has a product portfolio, which features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision. Its Dry Eye segment has a product portfolio, which consists of the TearCare System for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids. The company sells both systems through a direct sales model.
Contact
IPO
Employees
Officers
The intrinsic value of one SGHT stock under the Base Case scenario is 6.9 USD.
Compared to the current market price of 4.66 USD, Sight Sciences Inc is Undervalued by 32%.